Your pathway transformation partner
Underpinned by one technology platform, iPLATO is transforming primary care and population health through high-impact, multi-channel patient engagement.
Together with innovation partners, our solutions transform overburdened and fragmented healthcare routes into streamlined digital-first patient pathways.
Your pathway transformation partner
Underpinned by one technology platform, iPLATO is transforming primary care and population health through high-impact, multi-channel patient engagement.
Together with innovation partners, our solutions transform overburdened and fragmented healthcare routes into streamlined digital-first patient pathways.
Partnership in numbers...
Over 50%
of NHS Payers deploy iPLATO
34m
Patient network
2,518
of GPs surgeries use iPLATO
2.8m
Health-conscious patients on myGP app
Every day, our solutions...
- Empower millions of patients and carers to take control of their healthcare
- Improve patient outcomes and reduce health inequalities
- Support financial sustainability – reducing overall costs of care while maximizing provider revenue and resource utilisation
- Improve collaboration between clinicians and other care professionals
- Transform the patient and clinician experience of care
- Address workforce challenges
Don’t take our word for it?
Our Products
Population Health Service
A market leading multi-media mass communication solution used by Public Health England and ICBs to increase the engagement of their population with key public health metrics.
myGP app
The largest independent medical services platform in the UK, myGP connects over 2.8m patients to almost 50,000 clinicians and the services of tens of thousands of pharmacies.
Connect
Redressing the power imbalance between patients and clinicians — allowing GPs to seamlessly communicate with their patients, and patients to take an active, empowered role in their own health and wellbeing.
Solutions
iPLATO’s digital-first NHS Health Checks
Cardiovascular disease is responsible for 1 in 4 deaths each year: 7.6m people are reported to be living with CVD, costing £15.8bn to the wider economy.
iPLATO’s Smoking Patient Questionnaire saves time and money for GP practices
Case study from Haslington Surgery, Cheshire CCG: The practice sent out a smoking status myGP Patient Questionnaire to a group of patients, out of which 651 confirmed that they smoked and subsequently received smoking cessation advice.
iPLATO’s myGP increased self-referrals to Talking Therapies / IAPT
Working across nine Talking Therapy Service hubs across London and Bedfordshire, myGP deployed targeted SMS messages to drive self-referrals for IAPT services. Patients were targeted by age and gender, with each SMS message including three options for them to self-refer
Interested in joining the team?
Does impactful work with a meaningful mission excite you? iPLATO’s culture for innovation means we are always on
the look out for new talent.